Morten Persson

1.0k total citations
25 papers, 876 citations indexed

About

Morten Persson is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Morten Persson has authored 25 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Cancer Research. Recurrent topics in Morten Persson's work include Peptidase Inhibition and Analysis (11 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and Protease and Inhibitor Mechanisms (9 papers). Morten Persson is often cited by papers focused on Peptidase Inhibition and Analysis (11 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and Protease and Inhibitor Mechanisms (9 papers). Morten Persson collaborates with scholars based in Denmark, United States and Norway. Morten Persson's co-authors include Andreas Kjær, Jacob Madsen, Michael Ploug, Karina Juhl, Jesper Tranekjær Jørgensen, Dorthe Skovgaard, Malene Brandt-Larsen, Søren Østergaard, Palle Rasmussen and Klaus Brasso and has published in prestigious journals such as PLoS ONE, Scientific Reports and The Journal of Pathology.

In The Last Decade

Morten Persson

25 papers receiving 868 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Morten Persson Denmark	17	352	305	270	232	210	25	876
Aya Sugyo Japan	19	311 0.9×	364 1.2×	109 0.4×	272 1.2×	198 0.9×	65	848
Xiaoxia Xu China	18	310 0.9×	249 0.8×	155 0.6×	174 0.8×	142 0.7×	54	731
Anton G.T. Terwisscha van Scheltinga Netherlands	19	460 1.3×	507 1.7×	104 0.4×	293 1.3×	247 1.2×	30	1.0k
Samantha Y.A. Terry United Kingdom	19	315 0.9×	474 1.6×	88 0.3×	219 0.9×	186 0.9×	49	851
Thinzar M. Lwin United States	18	425 1.2×	100 0.3×	220 0.8×	395 1.7×	160 0.8×	62	1.1k
Arris J. Henderson United States	8	424 1.2×	320 1.0×	186 0.7×	454 2.0×	128 0.6×	8	1.0k
Gang Ren China	20	270 0.8×	474 1.6×	83 0.3×	288 1.2×	251 1.2×	62	1.0k
Ingrid Moen Norway	8	187 0.5×	112 0.4×	415 1.5×	393 1.7×	139 0.7×	16	934
Hitomi Sudo Japan	17	235 0.7×	289 0.9×	100 0.4×	246 1.1×	167 0.8×	56	766
June‐Key Chung South Korea	24	328 0.9×	704 2.3×	242 0.9×	235 1.0×	312 1.5×	58	1.4k

Countries citing papers authored by Morten Persson

Since Specialization

Citations

This map shows the geographic impact of Morten Persson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morten Persson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morten Persson more than expected).

Fields of papers citing papers by Morten Persson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morten Persson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morten Persson. The network helps show where Morten Persson may publish in the future.

Co-authorship network of co-authors of Morten Persson

This figure shows the co-authorship network connecting the top 25 collaborators of Morten Persson. A scholar is included among the top collaborators of Morten Persson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morten Persson. Morten Persson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kiss, Katalin, Giedrius Lelkaitis, Karina Juhl, et al.. (2017). Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer. BMC Cancer. 17(1). 572–572. 34 indexed citations

Skovgaard, Dorthe, Morten Persson, & Andreas Kjær. (2017). Urokinase Plasminogen Activator Receptor–PET with 68 Ga-NOTA-AE105. PET Clinics. 12(3). 311–319. 10 indexed citations

Skovgaard, Dorthe, Morten Persson, & Andreas Kjær. (2017). Imaging of Prostate Cancer Using Urokinase-Type Plasminogen Activator Receptor PET. PET Clinics. 12(2). 243–255. 7 indexed citations

Skovgaard, Dorthe, Morten Persson, Malene Brandt-Larsen, et al.. (2016). Safety, Dosimetry, and Tumor Detection Ability of ⁶⁸Ga-NOTA-AE105: First-in-Human Study of a Novel Radioligand for uPAR PET Imaging. Journal of Nuclear Medicine. 58(3). 379–386. 69 indexed citations

Skovgaard, Dorthe, Morten Persson, & Andreas Kjær. (2016). PET imaging of urokinase-type plasminogen activator receptor (uPAR) in prostate cancer: current status and future perspectives. Clinical and Translational Imaging. 4(6). 457–465. 11 indexed citations

Kriegbaum, Mette C., Annette Füchtbauer, Gert H. Hansen, et al.. (2016). C4.4A gene ablation is compatible with normal epidermal development and causes modest overt phenotypes. Scientific Reports. 6(1). 25833–25833. 10 indexed citations

Juhl, Karina, et al.. (2016). Peptide-Based Optical uPAR Imaging for Surgery: In Vivo Testing of ICG-Glu-Glu-AE105. PLoS ONE. 11(2). e0147428–e0147428. 35 indexed citations

Persson, Morten, Malene Brandt-Larsen, Dorthe Skovgaard, et al.. (2015). Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma. Journal of Nuclear Medicine. 57(2). 272–278. 32 indexed citations

Persson, Morten, Dorthe Skovgaard, Malene Brandt-Larsen, et al.. (2015). First-in-human uPAR PET: Imaging of Cancer Aggressiveness. Theranostics. 5(12). 1303–1316. 96 indexed citations

10.

Persson, Morten, Karina Juhl, Palle Rasmussen, et al.. (2014). uPAR Targeted Radionuclide Therapy with ¹⁷⁷Lu-DOTA-AE105 Inhibits Dissemination of Metastatic Prostate Cancer. Molecular Pharmaceutics. 11(8). 2796–2806. 37 indexed citations

11.

Persson, Morten, Masood Hosseini, Jacob Madsen, et al.. (2013). Improved PET Imaging of uPAR Expression Using new ⁶⁴Cu-labeled Cross-Bridged Peptide Ligands: Comparative in vitro and in vivo Studies. Theranostics. 3(9). 618–632. 44 indexed citations

12.

Persson, Morten & Andreas Kjær. (2013). Urokinase‐type plasminogen activator receptor (uPAR) as a promising new imaging target: potential clinical applications. Clinical Physiology and Functional Imaging. 33(5). 329–337. 38 indexed citations

13.

Persson, Morten, Henrik H. El Ali, Tina Binderup, et al.. (2013). Dosimetry of 64Cu-DOTA-AE105, a PET tracer for uPAR imaging. Nuclear Medicine and Biology. 41(3). 290–295. 22 indexed citations

14.

Jørgensen, Jesper Tranekjær, Morten Persson, Jacob Madsen, & Andreas Kjær. (2013). High tumor uptake of 64Cu: Implications for molecular imaging of tumor characteristics with copper-based PET tracers. Nuclear Medicine and Biology. 40(3). 345–350. 70 indexed citations

15.

Persson, Morten, Hongguang Liu, Jacob Madsen, Zhen Cheng, & Andreas Kjær. (2013). First 18F-labeled ligand for PET imaging of uPAR: In vivo studies in human prostate cancer xenografts. Nuclear Medicine and Biology. 40(5). 618–624. 40 indexed citations

16.

Persson, Morten, Jacob Madsen, Søren Østergaard, et al.. (2012). Quantitative PET of Human Urokinase-Type Plasminogen Activator Receptor with ⁶⁴Cu-DOTA-AE105: Implications for Visualizing Cancer Invasion. Journal of Nuclear Medicine. 53(1). 138–145. 70 indexed citations

17.

Persson, Morten, Palle Rasmussen, Jacob Madsen, Michael Ploug, & Andreas Kjær. (2012). New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts. Nuclear Medicine and Biology. 39(7). 962–969. 34 indexed citations

18.

Persson, Morten, Jacob Madsen, Søren Østergaard, Michael Ploug, & Andreas Kjær. (2011). 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers. Nuclear Medicine and Biology. 39(4). 560–569. 49 indexed citations

19.

Kriegbaum, Mette C., Morten Persson, Warner Alpízar‐Alpízar, et al.. (2011). Rational Targeting of the Urokinase Receptor (uPAR): Development of Antagonists and Non-Invasive Imaging Probes. Current Drug Targets. 12(12). 1711–1728. 60 indexed citations

20.

Petersen, Kamille Dumong, et al.. (2008). Monitoring the effect of belinostat in solid tumors by H4 acetylation. Apmis. 116(5). 382–392. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact